Thomas Booth
Papers
1
Total Citations
2
H-Index
1
About
Thomas Booth is a synthetic biologist and bioengineer whose research focuses on unlocking the metabolic potential of *Streptomyces* bacteria—nature’s most prolific producers of antibiotics and other bioactive compounds. His work sits at the intersection of molecular engineering, automation, and bioinformatics, with a particular emphasis on developing accessible, high-throughput tools for genetic manipulation. Booth’s most notable contribution is the development of **ActinoMation**, a literate programming approach for medium-throughput robotic conjugation of *Streptomyces* spp. This innovative platform integrates computational and wet-lab workflows to streamline the engineering of these genetically recalcitrant organisms, making advanced molecular tools—including CRISPR-based systems—more practical for non-specialist labs. Though his career is still early, his work has already garnered attention (2 citations for his flagship 2024 paper) for its potential to accelerate natural product discovery. By democratizing access to robotic conjugation, Booth is helping to bridge the gap between bioinformatics predictions and experimental validation, a critical step toward finding new antibiotics. His approach exemplifies how automation and open-source software can transform microbial engineering, positioning him as a rising voice in synthetic biology and natural product research.
Research Focus
Key Achievements
Top Papers
- 1